Vishal Singal

Opinion author

Vishal Singal is a partner at Beghou and head of its solutions portfolio, with a focus on next-generation therapy and patient engagement.

hub and spoke model concept. Distribution model with main center (hub) and branches (spoke). supply chain management concept vector illustration.

Opinion

CAR Ts will only treat autoimmune diseases if we can scale delivery

Biopharmas developing CAR T therapies for autoimmune indications face major barriers to maximizing the market. Advances in the provider ecosystem and clinical infrastructure, as well as access and education, will be key to launching at scale.

August 27, 2026

6 min read

Vishal Singal